Sort   by:  
 Page size 
Introduction: In addition to the well-known cartilage extracellular matrix-related expression of Sox9, we demonstrated that chondrogenic differentiation of progenitor cells is driven by a sharply defined bi-phasic expression of Sox9: an immediate early and a late (extracellular matrix associated) ph...
ORGANISM(S): Mus musculus 
Despite the success of BCR-ABL1 tyrosine kinase inhibitors (TKIs) like imatinib in treating chronic myeloid leukemia (CML), therapeutic resistance and disease persistence remain significant challenges. This study investigated the potential of BI-3406, a selective SOS1 inhibitor (a key activator of R...
ORGANISM(S): Mus musculus Homo sapiens 
2026-06-22 | GSE303378 | GEO
The clinical benefit of current mTOR inhibitors is limited, perhaps reflecting their intrinsic pharmacological profiles. Rapamycin analogs selectively inhibit mTORC1, but fail to suppress phosphorylation of the mTORC1 substrate 4EBP1, a translational repressor that is a key driver of oncogenic mTORC...
ORGANISM(S): Homo sapiens 
2021-04-05 | GSE138417 | GEO
The role of transfer (t)RNA cytosine methyl-transferases as epitranscriptomic regulators of brain proteomes remains unexplored. We report that fear memory and antidepressant-like behaviors are highly sensitive to bi-directional changes in Nsun2 tRNA methyltransferase activity in prefrontal cortex (P...
ORGANISM(S): Mus musculus (Mouse) 
2021-07-02 | PXD023437 | Pride
Sort   by:  
 Page size